French Study of 1,061: 100% Cured; No Adverse Effects
The reason that safe, effective therapeutics are being suppressed is that the covid vaccines would not be able to pass normal requirements for safety and efficacy, but those requirements can be waived under an "emergency" if there is no other treatment available. The current covid vaccines are NOT FDA approved, but allowed under an EUA (Emergency Use Authorization) only as long as there are no effective therapeutics. Without FDA approval, the vaccines are still considered experimental, and if you take one, you are essentially volunteering to be a part of a clinincal trial.
Click here for A CONVERSATION WITH DR. ZELENKO w/ Mikki Willis of Plandemic
Studies Confirm Dr Bartlett's Winning Covid Treatment (Safe inhaled steroid protocol)
The following video by Dr Andreas L Kalcker is also available in Spanish at this link:
Mas de 100 Casos de Covid-19 recuperados con CDS por medicos de Aememi
Watch on Bitchute: Laura-Lynn: Anthony Fauci has Known since 2005 that Chloroquine is an Effective Inhibitor (Cure and Prevention) of Coronaviruses
Richard Horton, the Editor-In-Chief of The Lancet, says:
“Now we are not going to be able to, basically, if this continues, publish any more clinical research data because the pharmaceutical companies are so financially powerful today, and are able to use such methodologies, as to have us accept papers which are apparently methodologically perfect, but which, in reality, manage to conclude what they want them to conclude.”
Paraphrased, this means Big Pharma can rig any data necessary to achieve publication of junk science in the journals.
This has all come to light via an individual who participated in a “closed” phone call, and who describes what he heard, including the assertion by journal editors that Big Pharma is a “criminal” operation (which is exactly what we’ve been reporting for nearly two decades).
Via the video description:
May 24, 2020: Philippe Douste-Blazy, Cardiology MD, Former France Health Minister and 2017 candidate for Director at WHO, former Under-Secretary-General of the United Nations, reveals that in a recent 2020 Chattam House closed door meeting, both the editors of the Lancet and the New England Journal of Medicine stated their concerns about the criminal pressures of Big Pharma on their publications. Things are so bad that it is not science any longer.
More: Hydroxychloroquine Lancet Study: Former French Health Minister Blows the Whistle
Study: A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies
White paper by James Lyons-Weiler, PhD: New Clinical and Translational Research Section of
“Science, Public Health Policy & The Law”
June 2, 2020: A lawsuit was filed by the Association of American Physicians and Surgeons against the FDA Comissioner and HHS Secretary Alex Azar for interfering with the availability of Hydroxychloroquine for use by doctors with their patients. COMPLAINT FOR DECLARATORY AND INJUNCTIVE RELIEF
"We the physicians of the world, united and loyal to the Hippocratic Oath, recognizing the profession of medicine as we know it is at a crossroad, are compelled to declare the following..."
The past 48 hours or so have seen a huge revelation: COVID-19 causes prolonged and progressive hypoxia (starving your body of Oxygen) by binding to the heme groups in hemoglobin in your red blood cells. People are simply desaturating (losing O2 in their blood), and that’s what eventually leads to organ failures that kill them, not any form of ARDS or pneumonia. All the damage to the lungs you see in CT scans are from the release of oxidative iron from the hemes, this overwhelms the natural defenses against pulmonary oxidative stress and causes that nice, always-bilateral ground glass opacity in the lungs. Patients returning for re-hospitalization days or weeks after recovery suffering from apparent delayed post-hypoxic leukoencephalopathy strengthen the notion COVID-19 patients are suffering from hypoxia despite no signs of respiratory ‘tire out’ or fatigue.
Here are a few more excerpts:
Your red blood cells carry Oxygen from your lungs to all your organs and the rest of your body. Red blood cells can do this thanks to hemoglobin, which is a protein consisting of four “hemes”. Hemes have a special kind of iron ion, which is normally quite toxic in its free form, locked away in its center with a porphyrin acting as it’s ‘container’. In this way, the iron ion can be ‘caged’ and carried around safely by the hemoglobin, but used to bind to Oxygen when it gets to your lungs.
Here’s where COVID-19 comes in. Its glycoproteins bond to the heme, and in doing so that special and toxic oxidative iron ion is “disassociated” (released). It’s basically let out of the cage and now freely roaming around on its own. This is bad for two reasons:
1) Without the iron ion, hemoglobin can no longer bind to Oxygen. Once all the hemoglobin is impaired, the red blood cell is essentially turned into a Freightliner truck cab with no trailer and no ability to store its cargo.. it is useless and just running around with COVID-19 virus attached to its porphyrin. All these useless trucks running around not delivering Oxygen is what starts to lead to desaturation, or watching the patient’s spo2 levels drop.
Think of it a lot like carbon monoxide poisoning, in which CO is bound to the hemoglobin, making it unable to carry Oxygen.
Only in this case, unlike CO poisoning in which eventually the CO can break off, the affected hemoglobin is permanently stripped of its ability to carry o2 because it has lost its iron ion.
2) That little iron ion, along with millions of its friends released from other hemes, are now floating through your blood freely. As I mentioned before, this type of iron ion is highly reactive and causes oxidative damage.
...with COVID-19...
it’s just too much iron and it begins to overwhelm your lungs’ countermeasures, and thus begins the process of pulmonary oxidative stress. This leads to damage and inflammation, which leads to all that nasty stuff and damage you see in CT scans of COVID-19 patient lungs. Ever noticed how it’s always bilateral? (both lungs at the same time) Pneumonia rarely ever does that, but COVID-19 does… EVERY. SINGLE. TIME.
And how chloroquine works
How does chloroquine work? Same way as it does for malaria. You see, malaria is this little parasite that enters the red blood cells and starts eating hemoglobin as its food source. The reason chloroquine works for malaria is the same reason it works for COVID-19.
The same mechanism that stops malaria from getting its hands on hemoglobin and gobbling it up seems to do the same to COVID-19 (essentially little snippets of DNA in an envelope) from binding to it. On top of that, Hydroxychloroquine (an advanced descendant of regular old chloroquine) lowers the pH which can interfere with the replication of the virus.
Fauci knew about HCQ in 2005 -- nobody needed to die
“Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.” (Emphasis mine throughout.) Write the researchers, “We report...that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”
Dr. Fauci has known for 15 years that chloroquine and it’s even milder derivative hydroxychloroquine (HCQ) will not only treat a current case of coronavirus (“therapeutic”) but prevent future cases (“prophylactic”). So HCQ functions as both a cure and a vaccine.
Dr Barke explains why it's so important to get the country open as quickly and safely as possible.
Dr. Richard Bartlett is reporting a 100% cure rate. Other countires are reporting similar results. It's an inexpensive corticosteroid which has been used safely for asthma for decades. No side effects.
Laura Ingraham interviews a Texas doctor about her experience in treating Covid patients with hydroxychloroquine, and CVS and Walgreens pharmacies refusing to fill her life-saving scripts.
Dave Cullen interviews with Doloroes Cahill, PhD
Starting around 11:50 her key points are:
1. Your immune system clears the virus after 10 days;
2. You're then immune for life.
3. Unless you have something like cystic fibrosys, there is limited risk.
4. No need for the lockdown.
6. If malnourished take vitamin C vitamin D3 and zinc - help your immune system recover to where it can fight the virus. 80 - 90% of people would have no symptoms if their immune system is functioning. Then take a 3 tablets over 3 days of hyroxycloroquine which are good for 3 weeks (200 mg each) - and you're good to go. Older people (>80) should quarantine. But, out of 800 old people doing the above in NY, only 4 had to go to hospital after getting the virus. Virus doesn't take long to circulate through the population and the globe and then get "cleared". Takes about 3 - 4 weeks max for the virus to go around the world and get "cleared'>
7. Between 7 and 15% of the Irish pop would have had the antibodies BEFORE COV-19 was front of mind.
8. Some people won't have antibodies because of blood type - but that is because Virus has no entry point into their cells to replicate.
NEW YORK, NY: Leading critical care specialists at five academic or major hospitals who together have formed the Front Line COVID-19 Critical Care Working Group, have released a protocol for treating patients who arrive in hospitals with COVID-19.
“I think patients are dying needlessly and I think that this is a terrible shame that we’re allowing this to happen. It is an outright shame. We have effective therapies that can alter the course of the disease. We need to institute them early, aggressively, and we need to prevent patients deteriorating and landing on a ventilator. Once they land on a ventilator, we know the course is prolonged, the mortality may be up to 60 to 70%. It takes them a long time to get off the ventilator and we really have no idea of their functional capacity once they get off the ventilator. We have to do everything in our power to aggressively treat them to prevent them going on to the mechanical ventilator.” -Dr. Paul Marik, Eastern Virginia Medical School; Department of Internal Medicine; Chief, Pulmonary and Critical Care Medicine
“I think it’s really important to treat patients for the disease they have and not for the disease we want to give them, or we think they have… This is not typical ARDS; and if you intubate them early and put them on a ventilator, you’re going to damage their lungs. You’re going to harm them…” -Dr. Paul Marik
Based on available research, the experience in China reflected by the Shanghai expert commission, and their decades-long professional experiences in Intensive Care Units around the country, the five experts strongly urge fellow physicians to immediately adopt a change in strategy by delivering powerful therapies earlier in the disease course, prior to admission to the ICU or the need for a mechanical ventilator. More
See also: "Our MATH+ protocol saves lives. So why isn’t the world using it?"
The World Health Organization and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from a little-known US healthcare analytics company, also calling into question the integrity of key studies published in some of the world’s most prestigious medical journals.
A Guardian investigation can reveal the US-based company Surgisphere, whose handful of employees appear to include a science fiction writer and an adult-content model, has provided data for multiple studies on Covid-19 co-authored by its chief executive, but has so far failed to adequately explain its data or methodology.
Data it claims to have legitimately obtained from more than a thousand hospitals worldwide formed the basis of scientific articles that have led to changes in Covid-19 treatment policies in Latin American countries. It was also behind a decision by the WHO and research institutes around the world to halt trials of the controversial drug hydroxychloroquine. On Wednesday, the WHO announced those trials would now resume.
Two of the world’s leading medical journals – the Lancet and the New England Journal of Medicine – published studies based on Surgisphere data. The studies were co-authored by the firm’s chief executive, Sapan Desai.
Late on Tuesday, after being approached by the Guardian, the Lancet released an “expression of concern” about its published study. The New England Journal of Medicine has also issued a similar notice.
An independent audit of the provenance and validity of the data has now been commissioned by the authors not affiliated with Surgisphere because of “concerns that have been raised about the reliability of the database”. More
UPDATE 6/5/2020: The Lancet's Hydroxy-chloroquine Paper Retracted by Authors
My name is Brian C. Procter MD and I am a Board-Certified Family Physician in McKinney, Texas. I am a colleague of Dr. Ivette Lozano that you interviewed a few weeks ago. I understand that you are trying to get the truth out about hydroxychloroquine.
I respectfully suggest that there is a much bigger issue/story here. Most commentators are discussing inpatient treatment only. If patients are admitted to the ICU then their chances of survival are dismal. But what happens when we treat patients 3-6 weeks earlier, when they first develop symptoms? I have been treating COVID-19 patients in the outpatient trenches for over 2 months now just like Dr. Lozano. I like her, I am using Hydroxychloroquine, azithromycin, losartan, aspirin, and zinc (all for less than $50 at my local pharmacy). We have identified, diagnosed, and successfully treated these patients at a relatively early point in the course of the disease.
It is these statistics that are amazing. I have treated over 50 patients without a single death, ventilator, or hospitalization. Dr. Lozano has treated twice that many with the same success. I even treated one patient that was discharged from a hospital the day before who was treated with IV fluids only for 4 days and released, still feeling terrible! We are two community docs using EARLY AGGRESSIVE OUTPATIENT TREATMENT to handle the disease with a 100% success rate (ZERO Admissions, ZERO).
Therefore, If we can treat patients EARLY for $50, we seem to be successful at preventing hospitalizations, ICUs, and death as well as saving tens of thousands of healthcare dollars per sick patient. My local ICU doctors have pleaded with me to keep doing what I am doing. The answer seems to be EARLY AGGRESSIVE OUTPATIENT TREATMENT and NOT contact tracing (which is communism and ! cannot even get the Public Health Dept on the phone), quarantine (which destroys millions of lives), wearing masks (which is ridiculous as a long term solution w/o proven data), a vaccine (by the time we get it, likely won't need it), social distancing (which won't sustain or GDP with 25% occupancy), testing (ALL tests have a high false negative rate up around 20-30%), or watchful waiting (a tactic that has needlessly resulted in 100,000 deaths).
We could also place all Nursing home patients on HCQ prophylaxis for 180 days on a voluntary basis of course. This could theoretically prevent thousands of needless hospitalizations and deaths.
In conclusion, if we treat COVID-19 just like anything else we treat (ie, the flu, pneumonia, a sinus infection, hypertension, and diabetes) early and aggressively with a regimen that costs $50 out of pocket or less with 100% success (which is a far better stat than treating all those other conditions), then why is the country shut down and doing social distancing? This political sham must stop.
The American people deserve to know they can go to their regular doctor and get treated early with a regimen that is completely safe and extremely effective, and they do not need to worry about ending up in the hospital and dying. The public is UNAWARE of this, please educate them with the truth. The country needs to return to normal NOW.
This is the REAL story. Please feel free to contact me with questions. My heart goes out to all those who have needlessly suffered and continue to suffer during this sham crisis and a disease that is extremely treatable if treated EARLY!
BRIAN C. PROCTER MD
June 3, 2020 Study Conclusions: Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly less hospitalizations and 5 times less all-cause deaths. There were no cardiac side effects.
Scholz, M.; Derwand, R.; Zelenko, V. COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study.
, PROFESSOR OF EPIDEMIOLOGY, YALE SCHOOL OF PUBLIC HEALTH
As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, "Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis." That article, published in the world's leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.
Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk. I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.
Since publication of my May 27 article, seven more studies have demonstrated similar benefit. In a lengthy follow-up letter, also published by AJE, I discuss these seven studies and renew my call for the immediate early use of hydroxychloroquine in high-risk patients. These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S., with no deaths; a controlled trial of more than 700 high-risk patients in Brazil, with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine; and another study of 398 matched patients in France, also with significantly reduced hospitalization risk. Since my letter was published, even more doctors have reported to me their completely successful use. More
A new study by Israeli researchers linked vitamin D deficiency with an increased risk of contracting coronavirus.
The study, done by the Leumit Health Services and researchers at the Bar-Ilan University, confirmed a correlation between low levels of vitamin D and the chances of contracting the disease.
The researchers also found a correlation between vitamin D deficiency and odds of being admitted into a hospital with coronavirus, but this link lost its relevance when other factors were also accounted for.
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline and infections.
Using the real-world data and Israeli cohort of 782 coronavirus positive patients and 7,807 coronavirus negative patients, the groups identified that low plasma vitamin D level appears to be an independent risk factor for coronavirus infection and, subsequently, hospitalization.
“The main finding of our study was the significant association of low plasma vitamin D level with the likelihood of coronavirus infection among patients who were tested for coronavirus, even after adjustment for age, gender, socio-economic status and chronic, mental and physical disorders,” said Dr. Eugene Merzon, Head of the Department of Managed Care and a leading researcher of the Leumit Kupat Cholim.
“Our finding is in agreement with the results of previous studies in the field. Reduced risk of acute respiratory tract infection following vitamin D supplementation has been reported,” said Dr. Ilan Green, Head of the Leumit Research Institute.
Dr. Dmitry Tworowski and Dr. Alessandro Gorohovski from Bar-Ilan University’s Azrieli Faculty of Medicine, suggest that the study could have a very significant impact.
“The main strength of our study is it’s being large, real-world, and population-based,” they explained.
In the U.K., the National Health Service recommended those staying indoors to consider taking 10 micrograms of vitamin D per day.
The Association of American Physicians and Surgeons (AAPS) is a leading non-partisan professional association of physicians across the United States.
Today the AAPS filed a motion for a preliminary injunction to compel the release to the public of hydroxychloroquine by the Food & Drug Administration (FDA) and the Department of Health & Human Services (HHS).
Here are two charts that show hydroxychloroquine’s effectiveness in treating the coronavirus.
Ascorbic acid is a crucial vitamin necessary for the correct functioning of the immune system. It plays a role in stress response and has shown promising results when administered to the critically ill. Quercetin is a well-known flavonoid whose antiviral properties have been investigated in numerous studies. There is evidence that vitamin C and quercetin co-administration exerts a synergistic antiviral action due to overlapping antiviral and immunomodulatory properties and the capacity of ascorbate to recycle quercetin, increasing its efficacy. Safe, cheap interventions which have a sound biological rationale should be prioritized for experimental use in the current context of a global health pandemic. We present the current evidence for the use of vitamin C and quercetin both for prophylaxis in high-risk populations and for the treatment of COVID-19 patients... More
Dr. David Brownstein has successfully treated more than a hundred patients with Covid 19, without a single fatality. FTC says it's illegal to publicize that.
Dr Brownstein's Center for Holistic Medicine
Dr. Bownstein's Peer Reviewed Covid Study: A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies
Institute for Pure and Applied Knowledge (IPAK): New Clinical and Translational Research Section of “Science, Public Health Policy & The Law”
Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset using triple therapy, including the combination of zinc with low-dose hydroxychloroquine, was associated with significantly fewer hospitalisations.
The aim of this study was to describe the outcomes of patients with coronavirus disease 2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose hydroxychloroquine and azithromycin (triple therapy) dependent on risk stratification. This was a retrospective case series study in the general practice setting. A total of 141 COVID-19 patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the year 2020 were included.
• Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.
• Significantly reduced hospitalisation rates in the treatment group.
• Reduced mortality rates in the treatment group.
• No cardiac side effects were observed.
Nov 23, 2020 - Analysis by Joseph Mercola
Melatonin is a hormone synthesized in your pineal gland and many other organs. While it is most well-known as a natural sleep regulator, it also has many other important functions.
Melatonin Is a potent antioxidant with the rare ability to enter your mitochondria, where it helps “prevent mitochondrial impairment, energy failure, and apoptosis of mitochondria damaged by oxidation,” notes a 2007 review published in Frontiers in Bioscience. It also helps recharge glutathione, and glutathione deficiency has been linked to COVID-19 severity
Melatonin has also been shown to play a role in viral infections and according to a June 2020 research paper in Life Sciences journal, it may be an important adjunct to COVID-19 treatment. According to the authors, melatonin curbs several pathological features of COVID-19, including:
They point out that melatonin is also “effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes.
”The scientific review paper, “Melatonin Potentials Against Viral Infections Including COVID-19: Current Evidence and New Findings,” published October 2020 in Virus Research journal, also summarizes the many potential mechanisms by which melatonin can protect against and reduce the severity of viral infections.
The authors reviewed research that looked at melatonin’s beneficial effects against a variety of viruses, including respiratory syncytial virus, Venezuelan equine encephalitis virus, viral hepatitis, viral myocarditis, Ebola, West Nile virus, and dengue virus. Based on these collective findings, they believe melatonin may offer similar protection against SARS-CoV-2.
Data from Cleveland Clinic also supports the use of melatonin. Here, the researchers analyzed patient data from the Cleveland Clinic’s COVID-19 registry using an artificial intelligence platform designed to identify drugs that may be repurposed.
Full article with references at Mercola.com
Gastroenterologist Professor Thomas Borody says the Australian government should allow the clinical trials of a drug he says is “amazingly effective” in treating the coronavirus. Professor Borody says Ivermectin, used in conjunction with two other drugs, has so-far been extremely successful in treating the deadly pathogen. He even says that, unlike a vaccine, Ivermectin is a "preventative" and a "cure". The drug is Federal Drug Agency and World Health Organisation approved; it is widely used for parasitic infections. However, Professor Borody told Sky News despite reports showing the drug is a successful COVID-19 treatment, he has been met with a “very negative reaction” by the federal government when he suggests the drug should be subjected to rigorous clinical trials.
Many doctors around the world started using the anti-malaria drug hydroxychloroquine (HCQ) early on in the COVID-19 pandemic. Among them is Dr. Vladimir Zelenko, a practicing physician in a Jewish community in Monroe County, New York.
He garnered national attention in March 2020 when he told radio host Sean Hannity that he’d had a near-100% success rate treating COVID-19 patients with HCQ, azithromycin and zinc sulfate for five days.1 “I’ve seen remarkable results; it really prevents progression of disease, and patients get better,” he said at the time.
In response, county health officials said Zelenko’s claims were “unsubstantiated” and urged residents to listen to public health officials.2 In this interview, he explains how HCQ works against COVID-19, and discusses the lies spun about the drug to suppress its widespread use. Zelenko had a very active Twitter account and would get millions of views on his tweets, and like many other truth tellers in this crazy pandemic, he was censored and recently removed from Twitter.
“When we have a large population of people that need to be treated, it has to be oral, cheap, safe and effective,” he says. “By the way, this is not new. This information was known in 2005 — even before.
There are papers with [Dr. Anthony] Fauci’s name on it, calling [HCQ] a miracle drug. Fauci called HCQ a vaccine. There’s a paper in which he called it an absolute dream treatment and vaccine. So, it’s conveniently forgotten but that’s what it is. It’s a matter of scientific record.”
What is most impressive to me is that he, through deep research and trial and error in the trenches, determined an incredibly effective protocol, and he did this under enormous personal health challenges. During the spring of last year, he was diagnosed with a type of pulmonary sarcoma that is typically considered terminal, and although improved, he continues to be under treatment for this condition.
As the SARS-CoV-2 swept through his tight-knit Jewish community, Zelenko was seeing anywhere from 50 to 250 patients per day. At this point, he’s treated more than 3,000 patients with COVID-19-related symptoms. Only one-third of them actually received the triple-drug regimen. The remaining two-thirds were in low-risk categories and did not need drug treatment.
In all, Zelenko has only had 15 patients who ended up requiring hospitalization, four of whom were intubated. All were eventually successfully extubated and recovered. The remaining 11 were admitted for intravenous antibiotics for pneumonia. In all, only three of his high-risk patients died from COVID-19, which puts the mortality rate for this treatment at just 0.3%.
“You cannot ignore that. That’s not even counting the risk stratification patients, which I chose not to treat. In other words, I was able to tell these patients, ‘I know you’re going to be fine. Go home, and you’ll be fine.’ And that has value.
If you include those, the mortality rate is even less. And this has been reproduced. You don’t have to listen to me. You can call it anecdotal all you want, but there are now Harvard professors of virology with 4,000 patient experiences.
Dr. George Fareed, for example, or Dr. Harvey Risch from Yale School of Epidemiology, who has shown that it’s absolutely statistically proven that HCQ used in the prehospital setting is absolutely effective. It’s impossible for it to be a mistake,” he says. More